SCHEMBL3702045

SCHEMBL3702045

O=Nc1ccc(C(=O)Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.45
▸ HSD17B10 Q99714 3/20 0.44
▸ KMT2A Q03164 3/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ NOS1 P29475 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2263327 0.82 TRPA1 (0.54) ALDH1A1KMT2AMAPK1CASP3SENP7
SCHEMBL2202425 0.82 TRPA1 (0.54) ALDH1A1KMT2AMAPK1CASP3SENP7
SCHEMBL20587670 0.81 ALDH1A1 (0.59) ALDH1A1TSHRTP53PKMHTT
SCHEMBL68148 0.81 ALDH1A1 (0.59) ALDH1A1TSHRTP53PKMHTT
SCHEMBL6038454 0.79 ADRA2A (0.56) ALDH1A1HSD17B10KMT2ACYP2C9TSHR
SCHEMBL28297389 0.78 ALDH1A1 (0.43) ALDH1A1KMT2ATSHRMAPK1TP53
SCHEMBL6758498 0.78 ALDH1A1 (0.64) ALDH1A1TSHRTP53PKMHTT
SCHEMBL28787222 0.78 ALDH1A1 (0.56) ALDH1A1TSHRTP53PKMHTT
Ammonia Solution, Strong SCHEMBL2023211 0.78 ALDH1A1 (0.56) ALDH1A1TSHRTP53PKMHTT
Hydrochloric Acid SCHEMBL2362644 0.78 ALDH1A1 (0.56) ALDH1A1TSHRTP53PKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238192-A1 VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF BLADE THERAPEUTICS, INC. 2021-08-05 — — US disclosed
WO-2019006295-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-01-03 — — WO disclosed
CN-108440299-A A method of preparing 4- nitro benzophenone class compounds 长沙理工大学 2018-08-24 — — CN disclosed
EP-2794620-B1 BODIPY STRUCTURE FLUORESCENCE PROBES FOR DIVERSE BIOLOGICAL APPLICATIONS NAT UNIV SINGAPORE (SG) 2017-11-15 — — EP disclosed
US-8338362-B2 Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity MASATOSHI HAGIWARA (JP) 2012-12-25 — — US disclosed
US-20120322814-A1 METHODS OF INHIBITING IRE1 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-12-20 — — US disclosed
US-8329728-B2 Synthesis and anti-proliferative effect of substituted imidazo[4,5-c]pyridine compounds SPELMAN COLLEGE (US) 2012-12-11 — — US disclosed
US-20120177572-A1 AMYLOID IMAGING AS A SURROGATE MARKER FOR EFFICACY OF ANTI-AMYLOID THERAPIES UNIVERSITY OF PITTSBURGH- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2012-07-12 — — US disclosed
US-20120095027-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES SPELMAN COLLEGE (US) 2012-04-19 — — US disclosed
US-20120095038-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES SPELMAN COLLEGE (US) 2012-04-19 — — US disclosed
US-7947723-B2 Synthesis and anti-proliferative effect of benzimidazole derivatives SPELMAN COLLEGE (US) 2011-05-24 — — US disclosed
US-20100016359-A1 METHODS FOR CONTROLLING SR PROTEIN PHOSPHORYLATION, AND ANTIVIRAL AGENTS WHOSE ACTIVE INGREDIENTS COMPRISE AGENTS THAT CONTROL SR PROTEIN ACTIVITY MASATOSHI HAGIWARA 2010-01-21 — — US disclosed
WO-2007038684-A2 PYRROLE DERIVATIVES AS THERAPEUTIC COMPOUNDS MYRIAD GENETICS, INC. (US) 2007-04-05 — — WO disclosed
US-6743851-B2 MIXTURE CONTAINING TETRAZOLE NIPPON ZEON CO., LTD. (JP) 2004-06-01 — — US disclosed
US-6734248-B2 CONTAINING A 1H-TETRAZOLE OR A 5,5'-BIS-1H-TETRAZOLE NIPPON ZEON CO., LTD. (JP) 2004-05-11 — — US disclosed
EP-0822229-B1 POLYIMIDE RESIN COMPOSITION NIPPON ZEON CO (JP) 2003-07-30 — — EP disclosed
US-20020035196-A1 Polyimide film TANAKA AKIRA (JP) 2002-03-21 — — US disclosed
US-20020032273-A1 Pattern forming process using polyimide resin composition TANAKA AKIRA (JP) 2002-03-14 — — US disclosed
US-6310135-B1 PHOTOSENSITIVE RESINS WITH TETRAZOLE COMPOUND NIPPON ZEON CO., LTD. (JP) 2001-10-30 — — US disclosed
EP-0822229-A1 POLYIMIDE RESIN COMPOSITION NIPPON ZEON CO., LTD. (JP) 1998-02-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095027-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES TYMP, MKI67, CCNI ALDH1A1 864/4885HSD17B10 4291/4885KMT2A 2479/4885
US-20210238192-A1 VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF VCAM1, VAPB, ICAM1 ALDH1A1 995/4885HSD17B10 4635/4885KMT2A 4790/4885
US-20100016359-A1 METHODS FOR CONTROLLING SR PROTEIN PHOSPHORYLATION, AND ANTIVIRAL AGENTS WHOSE ACTIVE INGREDIENTS COMPRISE AGENTS THAT CONTROL SR PROTEIN ACTIVITY SRPK1, SRPK3, SRPK2 ALDH1A1 4854/4885HSD17B10 2617/4885KMT2A 3810/4885
US-20120177572-A1 AMYLOID IMAGING AS A SURROGATE MARKER FOR EFFICACY OF ANTI-AMYLOID THERAPIES TTR, APP, SAAL1 ALDH1A1 2498/4885HSD17B10 2432/4885KMT2A 4494/4885
US-20120322814-A1 METHODS OF INHIBITING IRE1 XBP1, DNAJC10, HSPA5 ALDH1A1 3454/4885HSD17B10 1953/4885KMT2A 4299/4885
US-20120095038-A1 SYNTHESIS AND ANTI-PROLIFERATIVE EFFECT OF BENZIMIDAZOLE DERIVATIVES MKI67, CCNI, TYMP ALDH1A1 949/4885HSD17B10 4139/4885KMT2A 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback